SEC Form 4 · accession 0001123292-19-000081
PRECIGEN, INC. · PGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joel D Liffman
Officer — SVP, Finance
Period of report
Jan 2, 2019
Accepted (ET)
Jan 4, 2019 · 6:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356090
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 2, 2019 | M | 9,766 | — | A | 89,266 | D | |
| Common Stock | Jan 4, 2019 | S | 3,725 | $7.03 | D | 85,541 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F3 | — | Jan 2, 2019 | M | 9,766 | D | — | — | Common Stock | 9,766 | 29,297 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of XON common stock.
- F2This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units.
- F3The restricted stock units were granted on January 2, 2018, and the remaining restricted stock units vest in three equal annual installments on each of January 2020, 2021 and 2022